Corvus Pharmaceuticals Inc
CRVS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$843.73M
Close$
$0.05
99.5% downside
Current Fair Value
99.5% downsideOvervalued by 99.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $843.73 Million |
|---|---|
| Enterprise Value | $825.56 Million |
| Earnings per Share | $-0.19 |
| Beta | 0.86 |
| Outstanding Shares | 92,368,013 |
Return
| Return on Equity | -24.02% |
|---|---|
| Return on Assets | -22.62% |
| Return on Invested Capital | -24.53% |
Valuation & Multiples
| P/E Ratio | -15.67 |
|---|---|
| PEG | -12.58 |
| Price to Sales | - |
| Price to Book Ratio | 4.85 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -14.92 |
| Enterprise Value to Net Income | -16 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 29, 2026
EPS Estimate
$-0.18
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
November 3, 2026
EPS Estimate
$-0.19
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 38.25% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.54%▼ 76.26% |
|---|---|
| Total Invested | $5.72M▼ 99.46% |
| Investors Holding | 29▼ 159.00% |
About Corvus Pharmaceuticals Inc
CEO: Richard Miller
